Burning Rock Biotech (BNR) Competitors $2.79 -0.08 (-2.75%) As of 05/2/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BNR vs. SERA, EUDA, QIPT, BDSX, BMGL, PIII, OPGN, CCM, ENZ, and MRAIShould you be buying Burning Rock Biotech stock or one of its competitors? The main competitors of Burning Rock Biotech include Sera Prognostics (SERA), EUDA Health (EUDA), Quipt Home Medical (QIPT), Biodesix (BDSX), Basel Medical Group (BMGL), P3 Health Partners (PIII), OpGen (OPGN), Concord Medical Services (CCM), Enzo Biochem (ENZ), and Marpai (MRAI). These companies are all part of the "healthcare" industry. Burning Rock Biotech vs. Sera Prognostics EUDA Health Quipt Home Medical Biodesix Basel Medical Group P3 Health Partners OpGen Concord Medical Services Enzo Biochem Marpai Sera Prognostics (NASDAQ:SERA) and Burning Rock Biotech (NASDAQ:BNR) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, community ranking, valuation, profitability, earnings, institutional ownership, dividends and media sentiment. Does the MarketBeat Community favor SERA or BNR? Sera Prognostics received 5 more outperform votes than Burning Rock Biotech when rated by MarketBeat users. Likewise, 38.46% of users gave Sera Prognostics an outperform vote while only 31.25% of users gave Burning Rock Biotech an outperform vote. CompanyUnderperformOutperformSera PrognosticsOutperform Votes1038.46% Underperform Votes1661.54% Burning Rock BiotechOutperform Votes531.25% Underperform Votes1168.75% Which has more risk & volatility, SERA or BNR? Sera Prognostics has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500. Comparatively, Burning Rock Biotech has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500. Is SERA or BNR more profitable? Sera Prognostics has a net margin of 0.00% compared to Burning Rock Biotech's net margin of -83.50%. Sera Prognostics' return on equity of -51.73% beat Burning Rock Biotech's return on equity.Company Net Margins Return on Equity Return on Assets Sera PrognosticsN/A -51.73% -36.94% Burning Rock Biotech -83.50%-60.68%-42.30% Do institutionals & insiders have more ownership in SERA or BNR? 54.6% of Sera Prognostics shares are owned by institutional investors. Comparatively, 30.0% of Burning Rock Biotech shares are owned by institutional investors. 15.8% of Sera Prognostics shares are owned by company insiders. Comparatively, 30.3% of Burning Rock Biotech shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Do analysts rate SERA or BNR? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sera Prognostics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Burning Rock Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media refer more to SERA or BNR? In the previous week, Sera Prognostics and Sera Prognostics both had 1 articles in the media. Sera Prognostics' average media sentiment score of 1.43 equaled Burning Rock Biotech'saverage media sentiment score. Company Overall Sentiment Sera Prognostics Positive Burning Rock Biotech Positive Which has better valuation & earnings, SERA or BNR? Sera Prognostics has higher earnings, but lower revenue than Burning Rock Biotech. Sera Prognostics is trading at a lower price-to-earnings ratio than Burning Rock Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSera Prognostics$77K1,423.41-$36.24M-$0.99-2.94Burning Rock Biotech$515.82M0.06-$92.07M-$1.88-1.48 SummarySera Prognostics beats Burning Rock Biotech on 12 of the 15 factors compared between the two stocks. Get Burning Rock Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BNR vs. The Competition Export to ExcelMetricBurning Rock BiotechMedical laboratories IndustryBusiness SectorNASDAQ ExchangeMarket Cap$28.58M$3.06B$22.31B$8.02BDividend YieldN/A31.27%2.59%4.22%P/E Ratio-0.9314.1131.1718.83Price / Sales0.06188.72172.62106.72Price / CashN/A57.5631.5134.62Price / Book0.264.685.604.33Net Income-$92.07M-$22.21M$194.12M$247.97M7 Day Performance-1.76%-0.13%2.52%3.18%1 Month Performance-29.37%4.74%20.04%8.13%1 Year Performance-65.43%8.28%30.30%5.01% Burning Rock Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BNRBurning Rock Biotech1.886 of 5 stars$2.79-2.8%N/A-63.2%$28.58M$515.82M-0.931,390Short Interest ↓Positive NewsHigh Trading VolumeSERASera Prognostics1.0732 of 5 stars$3.00-5.1%N/A-72.6%$112.99M$77,000.00-3.03120Short Interest ↓News CoverageEUDAEUDA Health1.1177 of 5 stars$3.74-2.3%N/A+108.5%$92.11M$3.81M0.002Upcoming EarningsNews CoverageQIPTQuipt Home Medical2.1592 of 5 stars$2.12+1.0%$6.25+194.8%-45.9%$91.35M$244.72M-12.47800BDSXBiodesix3.2823 of 5 stars$0.57+5.8%$2.95+417.5%-60.5%$83.47M$71.32M-1.46220Analyst ForecastNews CoverageGap UpBMGLBasel Medical GroupN/A$4.17-3.7%N/AN/A$76.96M$10.05M0.0036Positive NewsPIIIP3 Health Partners2.7601 of 5 stars$8.86-0.9%$16.25+83.4%-70.7%$63.63M$1.50B-10.55500Upcoming EarningsPositive NewsGap UpOPGNOpGenN/A$4.91+2.9%N/A+6.2%$41.03M$2.67M0.00100High Trading VolumeCCMConcord Medical Services0.5913 of 5 stars$6.01+13.0%N/A-4.7%$26.10M$471.70M0.00970Analyst ForecastShort Interest ↑Gap UpHigh Trading VolumeENZEnzo BiochemN/A$0.33-14.8%N/A-68.8%$17.03M$29.09M0.00520Analyst ForecastGap DownHigh Trading VolumeMRAIMarpaiN/A$1.00flatN/A-56.9%$14.90M$34.87M-0.38150Upcoming Earnings Related Companies and Tools Related Companies Sera Prognostics Competitors EUDA Health Competitors Quipt Home Medical Competitors Biodesix Competitors Basel Medical Group Competitors P3 Health Partners Competitors OpGen Competitors Concord Medical Services Competitors Enzo Biochem Competitors Marpai Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BNR) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredMassive red flag about American consumerWhy is the U.S. Dollar suddenly crashing? Pundits on either side of the aisle have been warning that the U....Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Burning Rock Biotech Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Burning Rock Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BNR Stock Free BNR Stock Alerts